Kesara Na-Bangchang และผู้แต่งคนอื่นๆ. (2024) The Failure of Repurposing Drug Therapies Based on in vitro and in vivo Studies: A Case Study of COVID-19. <i>Science & Technology Asia</i>, <i>29</i>(1), 226-238.Kesara Na-Bangchang และผู้แต่งคนอื่นๆ. "The Failure of Repurposing Drug Therapies Based on in vitro and in vivo Studies: A Case Study of COVID-19". Science & Technology Asia 29 (2024):226-238.Kesara Na-Bangchang และผู้แต่งคนอื่นๆ. The Failure of Repurposing Drug Therapies Based on in vitro and in vivo Studies: A Case Study of COVID-19. Research Administration Division:ม.ป.ท. 2024.